These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10879992
1. Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration. Burtin B, Duchateau J, Pignat JC, Donnelly F, Bousquet J. J Investig Allergol Clin Immunol; 2000; 10(2):66-70. PubMed ID: 10879992 [Abstract] [Full Text] [Related]
2. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers]. MMW Fortschr Med; 2003 May 29; 145(22):51. PubMed ID: 12866281 [No Abstract] [Full Text] [Related]
3. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis. Nunes C, Ladeira S. J Investig Allergol Clin Immunol; 2000 May 29; 10(1):20-3. PubMed ID: 10780795 [Abstract] [Full Text] [Related]
4. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM. Allergy Asthma Proc; 2014 May 29; 35(4):338-45. PubMed ID: 24992553 [Abstract] [Full Text] [Related]
5. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group. Allergy; 2008 Jul 29; 63(7):924-31. PubMed ID: 18588560 [Abstract] [Full Text] [Related]
6. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis. Murris-Espin M, Melac M, Charpentier JC, Didier A. Ann Allergy Asthma Immunol; 1998 May 29; 80(5):399-403. PubMed ID: 9609610 [Abstract] [Full Text] [Related]
7. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B. J Allergy Clin Immunol; 1996 Aug 29; 98(2):309-16. PubMed ID: 8757208 [Abstract] [Full Text] [Related]
8. [The efficacy of cetirizine in the treatment of perennial allergic rhinitis]. Pacor ML, Biasi D, Carletto A, Corrocher R. Recenti Prog Med; 1999 Jun 29; 90(6):325-6. PubMed ID: 10399471 [Abstract] [Full Text] [Related]
9. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS. Ann Allergy Asthma Immunol; 2002 Dec 29; 89(6):589-98. PubMed ID: 12487225 [Abstract] [Full Text] [Related]
11. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Ciebiada M, Ciebiada MG, Kmiecik T, DuBuske LM, Gorski P. J Investig Allergol Clin Immunol; 2008 Dec 29; 18(5):343-9. PubMed ID: 18973097 [Abstract] [Full Text] [Related]
12. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Ann Allergy Asthma Immunol; 1999 Oct 29; 83(4):311-7. PubMed ID: 10541423 [Abstract] [Full Text] [Related]
13. [Antihistaminics. Side effects also after raising dosage at the placebo level]. MMW Fortschr Med; 2003 May 29; 145(22):50-1. PubMed ID: 12866280 [No Abstract] [Full Text] [Related]
14. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group. Clin Ther; 2005 May 29; 27(5):543-53. PubMed ID: 15978303 [Abstract] [Full Text] [Related]
15. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group. J Allergy Clin Immunol; 2004 Oct 29; 114(4):838-44. PubMed ID: 15480324 [Abstract] [Full Text] [Related]
16. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Walter Canonica G, Bousquet J, Van Hammée G, Bachert C, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, XPERT Study Group. Respir Med; 2006 Oct 29; 100(10):1706-15. PubMed ID: 16723217 [Abstract] [Full Text] [Related]
17. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Potter PC, Paediatric Levocetirizine Study Group. Ann Allergy Asthma Immunol; 2005 Aug 29; 95(2):175-80. PubMed ID: 16136768 [Abstract] [Full Text] [Related]
18. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH, Briscoe M, Widlitz MD. J Allergy Clin Immunol; 1998 May 29; 101(5):638-45. PubMed ID: 9600501 [Abstract] [Full Text] [Related]
19. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome. Rinne J, Simola M, Malmberg H, Haahtela T. J Allergy Clin Immunol; 2002 Mar 29; 109(3):426-32. PubMed ID: 11897986 [Abstract] [Full Text] [Related]
20. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC. Pediatr Allergy Immunol; 2006 Feb 29; 17(1):49-54. PubMed ID: 16426255 [Abstract] [Full Text] [Related] Page: [Next] [New Search]